RVMD Revolution Medicines, Inc.

159.43USD-0.24%Mkt Cap: 34.48B USDP/E: —

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that bind…